Cargando…

P15-27. Community involvement and ethics in HIV vaccine trial in Nigeria

Detalles Bibliográficos
Autores principales:	Adeyemi, AO, Fakunle, O, Adesola, OA, Olaogun, O
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2767724/ http://dx.doi.org/10.1186/1742-4690-6-S3-P228

Ejemplares similares

Female sex workers and condom use: lessons for future HIV vaccine trial in Nigeria
por: Fakunle, O, et al.
Publicado: (2012)

HIV risk among men who have sex with men (MSM) in Nigeria: a potential population for HIV vaccine trial
por: Adeyemi, AO, et al.
Publicado: (2012)

P15-23. Community engagement strategies in the Canadian HIV vaccine initiative
por: Milsom, P, et al.
Publicado: (2009)

P17-27. Development of recombinant adenovirus 28 vectors for HIV vaccines
por: Ko, S, et al.
Publicado: (2009)

Community needs assessment of key populations-at-risk of HIV/AIDS in Nigeria's capital territory
por: Asuquo, Godwin, et al.
Publicado: (2014)

P15-19. Evaluating community engagement efforts in a large, multi-site, global HIV vaccine trials network
por: Maggard, K, et al.
Publicado: (2009)

P15-25. Preparation for HIV vaccine trials in Africa: barriers and facilitators for the establishment of a community advisory board in Burkina Faso
por: Berthe, A, et al.
Publicado: (2009)

P15-29 LB. From ethical principle to practice: Training the trainers
por: Hankins, CA, et al.
Publicado: (2009)

P15-26. Leveraging motivators to participation in HIV vaccine research in the age of Obama
por: Alexander, SB, et al.
Publicado: (2009)

P15-30 LB. An evaluation of prescreen recruitment data: enrolling racial/ethnic minorities in Phase I HIV vaccine clinical trials
por: Johnson, D, et al.
Publicado: (2009)

P15-11. Preventive HIV vaccine acceptability: a systematic review and meta-analysis
por: Newman, PA, et al.
Publicado: (2009)

P15-18. Behavioral and social science in HIV vaccine clinical research: workshop recommendations
por: Lau, C, et al.
Publicado: (2009)

P15-20. Developing a national policy agenda for the Canadian HIV vaccine initiative
por: Sarazin, V, et al.
Publicado: (2009)

P15-22. Potential synergies between HIV vaccines, microbicides and pre-exposure prophylaxis
por: Sarazin, V, et al.
Publicado: (2009)

A review of the HIV/AIDS situation in northeastern Nigeria
por: Garbati, Musa A, et al.
Publicado: (2011)

Reliability of Rapid Diagnostic Tests in the diagnosis of malaria amongst children in two communities in South West Nigeria
por: Bello, Ibrahim S, et al.
Publicado: (2014)

P15-15. Advocates' perspectives on community engagement in the HVTN 505
por: Warren, M, et al.
Publicado: (2009)

Controlling the spread of Hiv among long haulage workers in Nigeria
por: Benjamin, Evans, et al.
Publicado: (2012)

P15-07. Knowledge, attitudes, practices and willingness to participate in HIV vaccine trials among urban residents of Bamako, Mali, in West Africa, 2005–2009
por: Tounkara, K, et al.
Publicado: (2009)

Enfuvirtide in therapy at patients with HIV-infection and tuberculosis
por: Kravchenko, AV, et al.
Publicado: (2010)

P15-28. Attitudes and awareness of HIV vaccine research in HIV uninfected MSM in four US cities: Rochester, Boston, San Francisco and Philadelphia
por: Alexander, SB, et al.
Publicado: (2009)

New HIV peptide-based immunoassay resolves vaccine-induced seropositivity in HIV vaccine (Phase III) trial participants
por: Penezina, O, et al.
Publicado: (2012)

P15-01. Willingness to participate in actual preventive HIV vaccine phase I/IIa trial in Bangkok, Thailand
por: Hemachandra, A, et al.
Publicado: (2009)

Hospital based palliative care approach to HIV/AIDnt; a Nigeria experience
por: Oyebola, Folaju Olusegun
Publicado: (2010)

Microbial infections in HIV/AIDS women with abnormal vaginal discharge in Lagos, Nigeria
por: Otuonye, NM, et al.
Publicado: (2014)

Willingness to participate in HIV vaccine efficacy trials in a population of fishing communities, Uganda
por: Nanvubya, A, et al.
Publicado: (2012)

The effects of highly active antiretroviral therapy (HAART) of stavudine, lamivudine and nevirapine on the CD4 lymphocyte count of HIV-infected Africans: the Nigerian experience
por: Erhabor, Osaro, et al.
Publicado: (2009)

P16-11. HLA-B57/5801 induces preferential CD27 expression on HIV-Gag but not Nef specific central memory CD8+T cells controlling HIV
por: Xie, J, et al.
Publicado: (2009)

P15-12. Community advisory boards' successes and challenges in AIDS vaccine clinical trials: a Southern Africa experience
por: Mokhele, T
Publicado: (2009)

Histopathological review of prostate cancer in Lokoja, Nigeria
por: Oluwole, Olabode Peter, et al.
Publicado: (2011)

P14-11. Educating community medical providers about HIV vaccine induced seropositivity
por: Mark, KE, et al.
Publicado: (2009)

P15-17. Social media as a tool for engaging and educating audiences around HIV vaccine research and clinical trial participation
por: Sitar, S, et al.
Publicado: (2009)

Tuberculosis with pulmonary involvement in HIV patients
por: Fernandes, Lígia, et al.
Publicado: (2010)

Antimalarial treatment by health care providers in Port Harcourt, Nigeria
por: Ebong, Omotavo O, et al.
Publicado: (2012)

P19-27. Willingness of adolescents in Soweto, South Africa to participate in future HIV prevention trials
por: Makongoza, N, et al.
Publicado: (2009)

A case study of a national ethics committee: challenges in regulating HIV prevention research in Zimbabwe
por: Phiri-Shana, ME, et al.
Publicado: (2012)

P15-03. HIV vaccine funding trends entering a global recession: research and development (R&D) from 2000 – 2008
por: Fisher, K, et al.
Publicado: (2009)

P15-05. Evaluation and recommendations on good clinical laboratory practice (GCLP) guidelines for phase I-III HIV vaccine clinical trials
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2009)

P15-09. The potential global market size and public health value of hypothetical HIV-1 preventive vaccines with different levels of efficacy
por: Marzetta, CA, et al.
Publicado: (2009)

Success rate of an outreach PMTCT program in Nigeria
por: Herbertson, EC, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_hlfnpmadokgss4qoecvrithkjj